Retatrutide, from Soma, represents a significant breakthrough in body regulation. This unique medication combines incretin receptor function with GIP receptor agonist activation , demonstrating substantial results in trial studies for body loss . Experts believe Retatrutide is expected to offer a different option for people experiencing weight-rela